Clinical Trial Page
Clinical Trial Results:
A Double-blind, Proof of Concept Trial of the Use of Pegvisomant to Reduce Urinary Albumin Excretion in Type 1 and Type 2 Diabetic Patients Treated with Angiotensin Convertase Inhibitors/Angiotensin Receptor Blockers, with Persistent Albuminuria
| Summary | |
EudraCT number | 2004-001190-25 |
Trial protocol | LT CZ DE GB ES DK |
Global completion date | 16 Feb 2006 |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
| Results information | |
Results version number | v1(current) |
This version publication date | 27 Apr 2016 |
First version publication date | 07 Feb 2015 |
Other versions | |
Summary report(s) | A6291015 Public Disclosure Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.